AbbVie ABBV remains a dominant force in the immunology space, powered by the continued uptake of its two blockbuster medications, Skyrizi and Rinvoq. The robust demand for both drugs has helped the ...

The updated indications state that if TNF blockers are clinically inadvisable, patients may still be administered Rinvoq if they have previously received at least 1 approved systemic therapy. The Food ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a supplemental new drug application that updates the indication statement for upadacitinib ...

An analysis by language learning website Preply found that Massachusetts was the fifth hardest name for Americans to say correctly. It was also the fifth hardest state name to spell. The study found ...

The Food & Drug Administration granted AbbVie expanded approval for its Rinvoq drug intended to treat moderately to severely active ulcerative colitis and moderately to severely active Crohn's disease ...

NORTH CHICAGO - The U.S. Food and Drug Administration has approved an updated indication for AbbVie’s (NYSE:ABBV) RINVOQ (upadacitinib) for treating adults with moderately to severely active ...

The FDA approved a supplemental new drug application for the JAK inhibitor upadacitinib (Rinvoq, AbbVie) permitting its use in the treatment of adults with moderately to severely active ulcerative ...

While speaking to press about fertility treatments, Donald Trump struggled to pronounce the fertility medicine Pergoveris, then jokingly asked why it couldn't have a 'nice, simple name.' ‘Adult female ...

The US Food and Drug Administration (FDA) has approved AbbVie’s supplemental new drug application, updating the indication statement for Rinvoq (upadacitinib) to treat inflammatory bowel disease. This ...

AbbVie notched a huge win when it managed to extend patent exclusivity for a blockbuster drug. That drug, Rinvoq, drew in over $1.3 billion in sales last year. As in any month, September was eventful ...

Languages are either syllable-timed, where all the syllables in a word last for the same amount of time, even when syllables are stressed, or stress-timed, where stressed syllables are pronounced at ...